世界の止血剤&組織シーラント市場2022~2026:止血剤、組織シーラント&接着剤、フィブリンシーラント

■ 英語タイトル:Global Hemostats and Tissue Sealants Market 2022-2026

調査会社Technavio社が発行したリサーチレポート(データ管理コード:IRTNTR40802-22)■ 発行会社/調査会社:Technavio
■ 商品コード:IRTNTR40802-22
■ 発行日:2022年7月14日
■ 調査対象地域:ヨーロッパ、 アジア太平洋、 北米、 南米、 中東&アフリカ
■ 産業分野:医薬品
■ ページ数:約120
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の止血剤&組織シーラント市場2022~2026:止血剤、組織シーラント&接着剤、フィブリンシーラント]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Technavio社発行の最新調査レポートでは、世界の止血剤&組織シーラント市場規模が2022年から2026年まで年平均9.82%成長し、22.4億ドルに達すると予測しています。当書では、止血剤&組織シーラントの世界市場を総合的に調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(止血剤、組織シーラント&接着剤、フィブリンシーラント)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア、アメリカ、カナダ、ドイツ、イギリス、中国)、推進要因・課題・動向、企業状況、企業分析などの項目をまとめています。なお、当書に掲載されている企業情報には、Advanced Medical Solutions Group Plc、Artivion Inc.、B. Braun SE、Baxter International Inc.、Becton Dickinson and Co.、BioCer Entwicklungs GmbH、Biomup SA、Cardinal Health Inc.、CSL Ltd.、Hemostasis LLC、Integra Lifesciences Holdings Corp.などが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界の止血剤&組織シーラント市場規模:製品別
- 止血剤の市場規模2021-2026
- 組織シーラント&接着剤の市場規模2021-2026
- フィブリンシーラントの市場規模2021-2026
・顧客状況
・地域別状況
- 北米の止血剤&組織シーラント市場規模2021-2026
- ヨーロッパの止血剤&組織シーラント市場規模2021-2026
- アジアの止血剤&組織シーラント市場規模2021-2026
- アメリカの止血剤&組織シーラント市場規模2021-2026
- カナダの止血剤&組織シーラント市場規模2021-2026
- ドイツの止血剤&組織シーラント市場規模2021-2026
- イギリスの止血剤&組織シーラント市場規模2021-2026
- 中国の止血剤&組織シーラント市場規模2021-2026
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

Global Hemostats and Tissue Sealants Market 2022-2026

Technavio has been monitoring the hemostats and tissue sealants market and it is poised to grow by $ 2.24 bn during 2022-2026, accelerating at a CAGR of 9.82% during the forecast period. Our report on the hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the use of hemostats and tissue sealants in surgeries, the increasing prevalence of chronic diseases and related risk factors, and technological advances and new product launches.

The hemostats and tissue sealants market analysis includes the product segment and geographic landscape.
Technavio’s hemostats and tissue sealants market is segmented as below:

By Product
• Hemostats
• Tissue sealants and adhesives
• Fibrin sealants

By Geographical Landscape
• Europe
• APAC
• North America
• South America
• Middle East and Africa

This study identifies the increasing r and d focus on novel hemostats and tissue sealants as one of the prime reasons driving the hemostats and tissue sealants market growth during the next few years. Also, high growth potential in emerging countries and the growing trend of oncology tourism will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hemostats and tissue sealants market covers the following areas:
• Hemostats and tissue sealants market sizing
• Hemostats and tissue sealants market forecast
• Hemostats and tissue sealants market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hemostats and tissue sealants market vendors that include Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS. Also, the hemostats and tissue sealants market analysis report include information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

*** レポート目次(コンテンツ)***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product – Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Hemostats – Market size and forecast 2021-2026
o Exhibit 28: Chart on Hemostats – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Hemostats – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Hemostats – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Hemostats – Year-over-year growth 2021-2026 (%)
o 5.4 Tissue sealants and adhesives – Market size and forecast 2021-2026
o Exhibit 32: Chart on Tissue sealants and adhesives – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Tissue sealants and adhesives – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Tissue sealants and adhesives – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Tissue sealants and adhesives – Year-over-year growth 2021-2026 (%)
o 5.5 Fibrin sealants – Market size and forecast 2021-2026
o Exhibit 36: Chart on Fibrin sealants – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Fibrin sealants – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Fibrin sealants – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Fibrin sealants – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 Canada – Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.9 Germany – Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.10 UK – Market size and forecast 2021-2026
o Exhibit 74: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.11 China – Market size and forecast 2021-2026
o Exhibit 78: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Advanced Medical Solutions Group Plc
o Exhibit 89: Advanced Medical Solutions Group Plc – Overview
o Exhibit 90: Advanced Medical Solutions Group Plc – Business segments
o Exhibit 91: Advanced Medical Solutions Group Plc – Key offerings
o Exhibit 92: Advanced Medical Solutions Group Plc – Segment focus
o 10.4 Artivion Inc.
o Exhibit 93: Artivion Inc. – Overview
o Exhibit 94: Artivion Inc. – Business segments
o Exhibit 95: Artivion Inc. – Key offerings
o Exhibit 96: Artivion Inc. – Segment focus
o 10.5 B. Braun SE
o Exhibit 97: B. Braun SE – Overview
o Exhibit 98: B. Braun SE – Business segments
o Exhibit 99: B. Braun SE – Key news
o Exhibit 100: B. Braun SE – Key offerings
o Exhibit 101: B. Braun SE – Segment focus
o 10.6 Baxter International Inc.
o Exhibit 102: Baxter International Inc. – Overview
o Exhibit 103: Baxter International Inc. – Business segments
o Exhibit 104: Baxter International Inc. – Key news
o Exhibit 105: Baxter International Inc. – Key offerings
o Exhibit 106: Baxter International Inc. – Segment focus
o 10.7 Becton Dickinson and Co.
o Exhibit 107: Becton Dickinson and Co. – Overview
o Exhibit 108: Becton Dickinson and Co. – Business segments
o Exhibit 109: Becton Dickinson and Co. – Key news
o Exhibit 110: Becton Dickinson and Co. – Key offerings
o Exhibit 111: Becton Dickinson and Co. – Segment focus
o 10.8 Integra Lifesciences Holdings Corp.
o Exhibit 112: Integra Lifesciences Holdings Corp. – Overview
o Exhibit 113: Integra Lifesciences Holdings Corp. – Business segments
o Exhibit 114: Integra Lifesciences Holdings Corp. – Key news
o Exhibit 115: Integra Lifesciences Holdings Corp. – Key offerings
o Exhibit 116: Integra Lifesciences Holdings Corp. – Segment focus
o 10.9 Johnson and Johnson
o Exhibit 117: Johnson and Johnson – Overview
o Exhibit 118: Johnson and Johnson – Business segments
o Exhibit 119: Johnson and Johnson – Key news
o Exhibit 120: Johnson and Johnson – Key offerings
o Exhibit 121: Johnson and Johnson – Segment focus
o 10.10 Medtronic Plc
o Exhibit 122: Medtronic Plc – Overview
o Exhibit 123: Medtronic Plc – Business segments
o Exhibit 124: Medtronic Plc – Key news
o Exhibit 125: Medtronic Plc – Key offerings
o Exhibit 126: Medtronic Plc – Segment focus
o 10.11 Pfizer Inc.
o Exhibit 127: Pfizer Inc. – Overview
o Exhibit 128: Pfizer Inc. – Product / Service
o Exhibit 129: Pfizer Inc. – Key news
o Exhibit 130: Pfizer Inc. – Key offerings
o 10.12 Teleflex Inc.
o Exhibit 131: Teleflex Inc. – Overview
o Exhibit 132: Teleflex Inc. – Business segments
o Exhibit 133: Teleflex Inc. – Key news
o Exhibit 134: Teleflex Inc. – Key offerings
o Exhibit 135: Teleflex Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 136: Inclusions checklist
o Exhibit 137: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 138: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 139: Research methodology
o Exhibit 140: Validation techniques employed for market sizing
o Exhibit 141: Information sources
o 11.5 List of abbreviations
o Exhibit 142: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Product – Market share 2021-2026 (%)
Exhibits25: Data Table on Product – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Hemostats – Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Hemostats – Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Hemostats – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Hemostats – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Tissue sealants and adhesives – Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Tissue sealants and adhesives – Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Tissue sealants and adhesives – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Tissue sealants and adhesives – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Fibrin sealants – Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Fibrin sealants – Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Fibrin sealants – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Fibrin sealants – Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America – Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US – Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US – Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK – Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK – Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China – Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China – Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Advanced Medical Solutions Group Plc – Overview
Exhibits90: Advanced Medical Solutions Group Plc – Business segments
Exhibits91: Advanced Medical Solutions Group Plc – Key offerings
Exhibits92: Advanced Medical Solutions Group Plc – Segment focus
Exhibits93: Artivion Inc. – Overview
Exhibits94: Artivion Inc. – Business segments
Exhibits95: Artivion Inc. – Key offerings
Exhibits96: Artivion Inc. – Segment focus
Exhibits97: B. Braun SE – Overview
Exhibits98: B. Braun SE – Business segments
Exhibits99: B. Braun SE – Key news
Exhibits100: B. Braun SE – Key offerings
Exhibits101: B. Braun SE – Segment focus
Exhibits102: Baxter International Inc. – Overview
Exhibits103: Baxter International Inc. – Business segments
Exhibits104: Baxter International Inc. – Key news
Exhibits105: Baxter International Inc. – Key offerings
Exhibits106: Baxter International Inc. – Segment focus
Exhibits107: Becton Dickinson and Co. – Overview
Exhibits108: Becton Dickinson and Co. – Business segments
Exhibits109: Becton Dickinson and Co. – Key news
Exhibits110: Becton Dickinson and Co. – Key offerings
Exhibits111: Becton Dickinson and Co. – Segment focus
Exhibits112: Integra Lifesciences Holdings Corp. – Overview
Exhibits113: Integra Lifesciences Holdings Corp. – Business segments
Exhibits114: Integra Lifesciences Holdings Corp. – Key news
Exhibits115: Integra Lifesciences Holdings Corp. – Key offerings
Exhibits116: Integra Lifesciences Holdings Corp. – Segment focus
Exhibits117: Johnson and Johnson – Overview
Exhibits118: Johnson and Johnson – Business segments
Exhibits119: Johnson and Johnson – Key news
Exhibits120: Johnson and Johnson – Key offerings
Exhibits121: Johnson and Johnson – Segment focus
Exhibits122: Medtronic Plc – Overview
Exhibits123: Medtronic Plc – Business segments
Exhibits124: Medtronic Plc – Key news
Exhibits125: Medtronic Plc – Key offerings
Exhibits126: Medtronic Plc – Segment focus
Exhibits127: Pfizer Inc. – Overview
Exhibits128: Pfizer Inc. – Product / Service
Exhibits129: Pfizer Inc. – Key news
Exhibits130: Pfizer Inc. – Key offerings
Exhibits131: Teleflex Inc. – Overview
Exhibits132: Teleflex Inc. – Business segments
Exhibits133: Teleflex Inc. – Key news
Exhibits134: Teleflex Inc. – Key offerings
Exhibits135: Teleflex Inc. – Segment focus
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IRTNTR40802-22 )"世界の止血剤&組織シーラント市場2022~2026:止血剤、組織シーラント&接着剤、フィブリンシーラント" (英文:Global Hemostats and Tissue Sealants Market 2022-2026)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。